Records containing: Ulcerative Colitis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-07-01Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels
-
CLINICAL_TRIALS study record update · 2021-06-25Multi-interventional Program to Reduce Chronic Ileoanal Pouch Leaks in UC
-
CLINICAL_TRIALS study record update · 2021-06-23A Study to Evaluate the Pharmacokinetics of Adalimumab in Combination With Methotrexate for the Treatment of Patients With Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2021-06-15Phase III, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Etrolizumab During Induction and Maintenance in Patients With Moderate to Severe Active Ulcerative Colitis Who Have Been Previously Exposed to TNF Inhibitors
-
CLINICAL_TRIALS study record update · 2021-06-11A Phase III, Randomized, Multi-Centre, Double-blind, Double Dummy, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to ASACOL 0.8g Three Times Daily, in Subjects With Mild to Moderate Ulcerative Colitis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-06-08A Controlled Trial of Yoga in Pediatric Inflammatory Bowel Disease (IBD)
-
CLINICAL_TRIALS study record update · 2021-06-02Phase I Trial of Berberine in Subjects With Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2021-06-01Immunophenotypic Characterization of Crohn's Disease (CD) Responders to Vedolizumab
-
CLINICAL_TRIALS study record update · 2021-05-19Phase 1 Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2021-05-18Multicentric, Double-blind, Placebo Controlled Clinical Trial With 5-hydroxytryptophan (5-HTP) in Patients With Inflammatory Bowel Disease in Clinical and Biologic Remission: Effect on Fatigue Scores
-
CLINICAL_TRIALS study record update · 2021-05-18Registry and Biorepository for the Study of Inflammatory Bowel Diseases in Central Texas
-
CLINICAL_TRIALS study record update · 2021-05-12Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2021-05-11A Multi-center, Multi-national, Randomized, Double-blind, Placebo Controlled, Parallel Group, Phase IIa Study to Evaluate the Efficacy, Safety and Tolerability of an Anthocyanin-rich Extract (ACRE) in Patients With Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2021-05-07A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
-
CLINICAL_TRIALS study record update · 2021-05-06A Phase 3b, Randomized, Double-Blind, Parallel-Arm, Placebo- and Active- Controlled Treat-Through Study of Mirikizumab and Vedolizumab in Participants With Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2021-05-03A Phase 1b, Placebo-controlled, Study of the Safety and Efficacy of MET-2 in Patients With Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2021-04-29Endoscopic Ultrasound Determines Disease Activity in Crohn's Disease And Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2021-04-28Double-blinded Randomized Placebo Controlled Study: Fecal Microbiota Transplantation in the Treatment of Chronic Pouchitis
-
CLINICAL_TRIALS study record update · 2021-04-28Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2021-04-27Exploring the Use of a Reduced Sulfur Diet to Improve Disease Severity in Ulcerative Colitis: An 8-week Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2021-04-26A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
-
CLINICAL_TRIALS study record update · 2021-04-21Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2021-04-15A PHASE 3B/4, MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PARALLEL GROUP STUDY OF TOFACITINIB (CP-690,550) IN SUBJECTS WITH ULCERATIVE COLITIS IN STABLE REMISSION
-
CLINICAL_TRIALS study record update · 2021-04-05Phase III, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy (Induction of Remission) and Safety of Etrolizumab Compared With Adalimumab and Placebo in Patients With Moderate to Severe Ulcerative Colitis Who Are Naive to TNF Inhibitors
-
CLINICAL_TRIALS study record update · 2021-04-05A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study to Investigate the Safety and Efficacy of APD334 in Patients With Moderately to Severely Active Ulcerative Colitis